- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x OAA: OXALOACETATE ION(Non-covalent)
- 2 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
NAP.2: 30 residues within 4Å:- Chain A: G.13, A.14, S.15, R.16, G.17, F.18, A.40, R.41, S.42, A.67, D.68, L.69, N.99, A.100, A.101, T.102, L.125, I.154, S.155, Y.169, K.173, P.197, G.198, P.199, L.200, N.202, D.203, M.204, Q.205
- Ligands: OAA.1
30 PLIP interactions:30 interactions with chain A- Hydrophobic interactions: A:P.197
- Hydrogen bonds: A:S.15, A:S.15, A:R.16, A:R.16, A:F.18, A:R.41, A:S.42, A:D.68, A:L.69, A:N.99, A:A.101, A:Y.169, A:K.173, A:L.200, A:N.202, A:N.202, A:Q.205, A:Q.205
- Water bridges: A:S.15, A:R.16, A:R.16, A:G.19, A:R.41, A:R.41, A:G.70, A:N.99
- Salt bridges: A:R.16, A:R.16, A:R.41
NAP.5: 30 residues within 4Å:- Chain B: G.13, A.14, S.15, R.16, G.17, F.18, A.40, R.41, S.42, A.67, D.68, L.69, N.99, A.100, A.101, T.102, L.125, I.154, S.155, Y.169, K.173, P.197, G.198, P.199, L.200, N.202, D.203, M.204, Q.205
- Ligands: OAA.4
30 PLIP interactions:30 interactions with chain B- Hydrophobic interactions: B:P.197
- Hydrogen bonds: B:S.15, B:S.15, B:R.16, B:R.16, B:F.18, B:R.41, B:S.42, B:D.68, B:D.68, B:L.69, B:N.99, B:A.101, B:K.173, B:L.200, B:N.202, B:N.202, B:Q.205, B:Q.205
- Water bridges: B:S.15, B:R.16, B:G.19, B:R.41, B:R.41, B:G.70, B:N.99, B:D.203
- Salt bridges: B:R.16, B:R.16, B:R.41
- 2 x ASE: N-ACETYL SEROTONIN(Non-covalent)
ASE.3: 12 residues within 4Å:- Chain A: L.157, Y.163, W.166, A.196, G.198, P.199, L.217, K.220, L.221, D.256, Y.258
- Ligands: OAA.1
10 PLIP interactions:10 interactions with chain A- Hydrophobic interactions: A:L.157, A:L.157, A:Y.163, A:W.166, A:L.217, A:Y.258
- Hydrogen bonds: A:L.157, A:G.198, A:K.220
- Water bridges: A:D.256
ASE.6: 12 residues within 4Å:- Chain B: L.157, Y.163, W.166, A.196, G.198, P.199, L.217, K.220, L.221, D.256, Y.258
- Ligands: OAA.4
9 PLIP interactions:9 interactions with chain B- Hydrophobic interactions: B:L.157, B:L.157, B:Y.163, B:W.166, B:L.217, B:Y.258
- Hydrogen bonds: B:L.157, B:G.198, B:K.220
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Auerbach, G. et al., The 1.25 A crystal structure of sepiapterin reductase reveals its binding mode to pterins and brain neurotransmitters. EMBO J. (1997)
- Release Date
- 1999-03-30
- Peptides
- SEPIAPTERIN REDUCTASE: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x OAA: OXALOACETATE ION(Non-covalent)
- 2 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 2 x ASE: N-ACETYL SEROTONIN(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Auerbach, G. et al., The 1.25 A crystal structure of sepiapterin reductase reveals its binding mode to pterins and brain neurotransmitters. EMBO J. (1997)
- Release Date
- 1999-03-30
- Peptides
- SEPIAPTERIN REDUCTASE: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A